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Background
There is not enough evidence to support the use of combined Implantable Cardiac Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT) devices in all CRT candidates. Stronger predictors of malignant ventricular arrhythmia (VA) and sudden cardiac death (SCD) are required. The purpose of this study was to assess the value of myocardial scar extension and scar characterization (core and border zone) to predict VA in CRT patients.
Methods
A standard Contrast-enhanced Cardiac Magnetic Resonance (ce-CMR) was performed pre-implantation of CRT device in 78 cardiac heart failure patients (64±11 years) with ischemic and non-ischemic dilated cardiomyopathy. Systolic function was assessed by cine imaging. Myocardial scar was characterized by a standard 2D segmented gradient echo inversion-recovery sequence applied in sequential short axis slices. Total scar was expressed as percentage of LV mass and the core and border zone as percentage of total scar). Patients were followed every 6 months to look for appropriate ICD therapy episodes. However, the proportion of core was not significant (p = 0.662). The area under the ROC curve of total scar to predict VA was 0.94, and a cut-off value of <16% of LV mass had a 100% negative predictive value to exclude VA during follow-up.
Results

During
Conclusions
In TRC candidates with dilated cardiomyopathy of any etiology the extent of myocardial scar and the proportion of border zone predict the occurrence of VA. Assessment of scar burden and scar characterization using ce-CMR may be helpful to decide when combined ICD/CRT devices are indicated among CRT candidates.
